Bona fide disclosure requirements govern under-reporting penalties, and post-penalty immunity applications cannot secure available statutory protectio...
Certificate-of-origin verification procedure governs preferential customs benefits; denial without retroactive verification was set aside with consequ...
Disciplinary Committee jurisdiction and mandatory investigation requirements invalidated cancellation of an insolvency professional's registration and...
Retention of seized property survives where recorded reasons support proceeds of crime, while stayed investigation periods are excluded from limitatio...
Specified income of Baddi Barotiwala Nalagarh Development Authority receives conditional tax exemption, retrospectively covering its designated assess...
Page of 4788
Press 'Enter' after typing page number.
881 to 900 of 95752 Results
❮
❯
❯❯
0 / 200
Expand Note
Add to Folder
No Folders have been created
+
Are you sure you want to delete "My most important" ?
Seven new Standard Input Output Norms under the Chemical and Allied Products group prescribe permitted import inputs and quantities for specified export products, including theophylline, liraglutide injection, lumefantrine, meropenem formulations and ophthalmic solutions. The norms specify relevant bulk drugs, chemicals and sterile bulk materials as allowable inputs; for ophthalmic solutions, bulk-drug content must conform to the Drug Manufacturing Licence. The new entries enable Regional Authorities to issue Advance Authorisations directly in eligible cases without individual referral to the Norms Committee, promoting faster processing and uniform norm fixation.
Seven new Standard Input Output Norms under the Chemical and Allied Products group prescribe permitted import inputs and quantities for specified export products, including theophylline, liraglutide injection, lumefantrine, meropenem formulations and ophthalmic solutions. The norms specify relevant bulk drugs, chemicals and sterile bulk materials as allowable inputs; for ophthalmic solutions, bulk-drug content must conform to the Drug Manufacturing Licence. The new entries enable Regional Authorities to issue Advance Authorisations directly in eligible cases without individual referral to the Norms Committee, promoting faster processing and uniform norm fixation.
Note: It is a system-generated summary and is for quick reference only.